Literature DB >> 7592593

Differential activation of peroxisome proliferator-activated receptors by eicosanoids.

K Yu1, W Bayona, C B Kallen, H P Harding, C P Ravera, G McMahon, M Brown, M A Lazar.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that regulate gene transcription in response to peroxisome proliferators and fatty acids. PPARs also play an important role in the regulation of adipocyte differentiation. It is unclear, however, what naturally occurring compounds activate each of the PPAR subtypes. To address this issue, a screening assay was established using heterologous fusions of the bacterial tetracycline repressor to several members of the peroxisome proliferator-activated receptor (PPAR) family. This assay was employed to compare the activation of PPAR family members by known PPAR activators including peroxisome proliferators and fatty acids. Interestingly, the activation of PPARs by fatty acids was partially inhibited by the cyclooxygenase inhibitor indomethacin, which prevents prostaglandin synthesis. Indeed, prostaglandins PGA1 and 2, PGD1 and 2, and PGJ2-activated PPARs, while a number of other prostaglandins had no effect. We also screened a variety of hydroxyeicosatetraenoic acids (HETEs) for the ability to activate PPARs. 8(S)-HETE, but not other (S)-HETEs, was a strong activator of PPAR alpha. Remarkably, PPAR activation by 8(S)-HETE was stereoselective. In addition, 8(S)-HETE was able to induce differentiation of 3T3-L1 preadipocytes. These results indicate that PPARs are differentially activated by naturally occurring eicosanoids and related molecules.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7592593     DOI: 10.1074/jbc.270.41.23975

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  151 in total

1.  Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I.

Authors:  G Martin; H Duez; C Blanquart; V Berezowski; P Poulain; J C Fruchart; J Najib-Fruchart; C Glineur; B Staels
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

2.  Epidermis-type lipoxygenase 3 regulates adipocyte differentiation and peroxisome proliferator-activated receptor gamma activity.

Authors:  Philip Hallenborg; Claus Jørgensen; Rasmus K Petersen; Søren Feddersen; Pedro Araujo; Patrick Markt; Thierry Langer; Gerhard Furstenberger; Peter Krieg; Arjen Koppen; Eric Kalkhoven; Lise Madsen; Karsten Kristiansen
Journal:  Mol Cell Biol       Date:  2010-06-07       Impact factor: 4.272

3.  Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.

Authors:  W Yang; C Rachez; L P Freedman
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 4.  The COXes of Danio: from mechanistic model to experimental therapeutics.

Authors:  Stephen M Prescott; H Joseph Yost
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-01       Impact factor: 11.205

5.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 6.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 7.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

8.  Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells.

Authors:  Takayoshi Maiguma; Koji Fujisaki; Yoshinori Itoh; Kazutaka Makino; Daisuke Teshima; Fumi Takahashi-Yanaga; Toshiyuki Sasaguri; Ryozo Oishi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-08       Impact factor: 3.000

Review 9.  Diet, fatty acids, and regulation of genes important for heart disease.

Authors:  John P Vanden Heuvel
Journal:  Curr Atheroscler Rep       Date:  2004-11       Impact factor: 5.113

10.  Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes.

Authors:  Christelle Mérial-Kieny; Michel Lonchampt; Francis Cogé; Patrick Verwaerde; Jean-Pierre Galizzi; Jean A Boutin; Max Lafontan; Nigel Levens; Jean Galitzky; Michel Félétou
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.